Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...
This work delineates how Setd2-mediated epigenetic reprogramming overcomes developmental barriers in cloned embryos. Comparative analysis revealed that SCNT embryos exhibit excessive H3K4me3 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback